Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Testning af tilsætning af et antiangiogent lægemiddel (bevacizumab) til kemoterapi (carboplatin og paclitaxel) kombineret med immunterapi (pembrolizumab) til PMMR, TP53 muteret endometrial kræft

18. november 2026 opdateret af: National Cancer Institute (NCI)

A Randomized Phase II/III Trial of Carboplatin, Paclitaxel, Pembrolizumab Versus Carboplatin, Paclitaxel, Bevacizumab Versus Carboplatin, Paclitaxel, Pembrolizumab, Bevacizumab in the Treatment of pMMR, TP53 Mutated Advanced or Recurrent Endometrial Cancer

This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizumab in treating patients with stage III, IVA or IVB mismatch repair protein proficient (pMMR) and TP53 mutated endometrial cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has come back after a period of improvement (recurrent). Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Adding bevacizumab to the combination of carboplatin, paclitaxel and pembrolizumab may be more effective than the usual treatment combinations of carboplatin and paclitaxel with or without pembrolizumab in treating patients with advanced or recurrent pMMR and TP53 mutated endometrial cancer.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

PRIMARY OBJECTIVE:

I. To demonstrate that bevacizumab, an anti-VEGF antibody therapy, (or an anti-VEGF antibody biosimilar) in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab (the control arm) or carboplatin, paclitaxel, and bevacizumab in prolonging progression-free survival (PFS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.

SECONDARY OBJECTIVES:

I. To demonstrate that bevacizumab in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab or carboplatin, paclitaxel, and bevacizumab in prolonging overall survival (OS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.

II. To examine the impact of the addition of bevacizumab in combination with carboplatin and paclitaxel or with carboplatin, paclitaxel, and pembrolizumab on PFS and OS based on type of p53 immunohistochemistry (IHC) aberrancy (over expression/cytoplasmic expression versus null [complete absence of staining]) and mutation type.

III. To evaluate toxicity on treatment with bevacizumab when combined with carboplatin, paclitaxel, and/or pembrolizumab as assessed by Common Terminology Criteria for Adverse Events (CTCAE) version (v.)5.0.

IV. To explore the anti-tumor activity in each treatment arm as assessed by objective response rate in the subset of patients with measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM 1 (REFERENCE ARM): Patients receive paclitaxel intravenously (IV) over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional14 cycles. Additionally, patients undergo urine and blood sample collection and computed tomography (CT) or magnetic resonance imaging (MRI) throughout the study.

ARM 2 (EXPERIMENTAL TRIPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

ARM 3 (EXPERIMENTAL QUADRUPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

After completion of study treatment, patients are followed every 3 months for 2 years then every 6 months for up to 3 years.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

255

Fase

  • Fase 3

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forenede Stater, 35233
        • Rekruttering
        • University of Alabama at Birmingham Cancer Center
        • Ledende efterforsker:
          • Michael D. Toboni
        • Kontakt:
    • Alaska
      • Anchorage, Alaska, Forenede Stater, 99508
    • Arizona
      • Phoenix, Arizona, Forenede Stater, 85004
      • Tucson, Arizona, Forenede Stater, 85719
        • Rekruttering
        • Banner University Medical Center - Tucson
        • Kontakt:
        • Ledende efterforsker:
          • Marina D. Miller
      • Tucson, Arizona, Forenede Stater, 85719
        • Rekruttering
        • University of Arizona Cancer Center-North Campus
        • Kontakt:
        • Ledende efterforsker:
          • Marina D. Miller
    • Arkansas
      • Fayetteville, Arkansas, Forenede Stater, 72703
        • Rekruttering
        • Highlands Oncology Group - Fayetteville
        • Ledende efterforsker:
          • Joseph T. Beck
        • Kontakt:
      • Little Rock, Arkansas, Forenede Stater, 72205
        • Rekruttering
        • University of Arkansas for Medical Sciences
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 501-686-8274
        • Ledende efterforsker:
          • Heather R. Williams
      • Rogers, Arkansas, Forenede Stater, 72758
        • Rekruttering
        • Highlands Oncology Group - Rogers
        • Ledende efterforsker:
          • Joseph T. Beck
        • Kontakt:
      • Springdale, Arkansas, Forenede Stater, 72762
        • Rekruttering
        • Highlands Oncology Group
        • Ledende efterforsker:
          • Joseph T. Beck
        • Kontakt:
    • California
      • Carmichael, California, Forenede Stater, 95608
      • Carmichael, California, Forenede Stater, 95608
      • Dublin, California, Forenede Stater, 94568
        • Rekruttering
        • Kaiser Permanente Dublin
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
      • Elk Grove, California, Forenede Stater, 95758
      • Fremont, California, Forenede Stater, 94538
        • Rekruttering
        • Kaiser Permanente-Fremont
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Fresno, California, Forenede Stater, 93720
        • Rekruttering
        • Kaiser Permanente Fresno Orchard Plaza
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 833-574-2273
      • Los Angeles, California, Forenede Stater, 90048
        • Rekruttering
        • Cedars-Sinai Medical Center
        • Ledende efterforsker:
          • Emily N. Prendergast
        • Kontakt:
      • Los Angeles, California, Forenede Stater, 90033
        • Rekruttering
        • USC / Norris Comprehensive Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 323-865-0451
        • Ledende efterforsker:
          • Koji Matsuo
      • Los Angeles, California, Forenede Stater, 90033
        • Rekruttering
        • Los Angeles General Medical Center
        • Ledende efterforsker:
          • Koji Matsuo
        • Kontakt:
      • Modesto, California, Forenede Stater, 95356
        • Rekruttering
        • Kaiser Permanente- Modesto MOB II
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
      • Oakland, California, Forenede Stater, 94611
        • Rekruttering
        • Kaiser Permanente-Oakland
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Palo Alto, California, Forenede Stater, 94304
        • Rekruttering
        • Stanford Cancer Institute Palo Alto
        • Ledende efterforsker:
          • Kristin L. Bixel
        • Kontakt:
      • Rancho Mirage, California, Forenede Stater, 92270
        • Rekruttering
        • Eisenhower Medical Center
        • Ledende efterforsker:
          • Mark Genesen
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 760-834-3798
      • Rocklin, California, Forenede Stater, 95765
      • Roseville, California, Forenede Stater, 95661
        • Rekruttering
        • Kaiser Permanente-Roseville
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Sacramento, California, Forenede Stater, 95817
        • Rekruttering
        • University of California Davis Comprehensive Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 916-734-3089
        • Ledende efterforsker:
          • Nancy T. Nguyen
      • Sacramento, California, Forenede Stater, 95814
        • Rekruttering
        • Kaiser Permanente Downtown Commons
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: kpoct@kp.org
      • Sacramento, California, Forenede Stater, 95823
        • Rekruttering
        • Kaiser Permanente-South Sacramento
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Sacramento, California, Forenede Stater, 95816
      • San Francisco, California, Forenede Stater, 94115
        • Rekruttering
        • Kaiser Permanente-San Francisco
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • San Jose, California, Forenede Stater, 95119
        • Rekruttering
        • Kaiser Permanente-Santa Teresa-San Jose
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • San Leandro, California, Forenede Stater, 94577
        • Rekruttering
        • Kaiser Permanente San Leandro
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • San Rafael, California, Forenede Stater, 94903
        • Rekruttering
        • Kaiser San Rafael-Gallinas
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Santa Clara, California, Forenede Stater, 95051
        • Rekruttering
        • Kaiser Permanente Medical Center - Santa Clara
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Santa Rosa, California, Forenede Stater, 95403
        • Rekruttering
        • Kaiser Permanente-Santa Rosa
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • South San Francisco, California, Forenede Stater, 94080
        • Rekruttering
        • Kaiser Permanente-South San Francisco
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Vallejo, California, Forenede Stater, 94589
        • Rekruttering
        • Kaiser Permanente-Vallejo
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Walnut Creek, California, Forenede Stater, 94596
        • Rekruttering
        • Kaiser Permanente-Walnut Creek
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-mail: Kpoct@kp.org
      • Woodland, California, Forenede Stater, 95695
    • Colorado
      • Aurora, Colorado, Forenede Stater, 80045
        • Rekruttering
        • UCHealth University of Colorado Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Ledende efterforsker:
          • Bradley R. Corr
      • Colorado Springs, Colorado, Forenede Stater, 80909
        • Rekruttering
        • UCHealth Memorial Hospital Central
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 719-365-2406
        • Ledende efterforsker:
          • Bradley R. Corr
      • Colorado Springs, Colorado, Forenede Stater, 80920
        • Rekruttering
        • Memorial Hospital North
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 719-364-6700
        • Ledende efterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forenede Stater, 80524
        • Rekruttering
        • Poudre Valley Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 970-297-6150
        • Ledende efterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forenede Stater, 80528
        • Rekruttering
        • Cancer Care and Hematology-Fort Collins
        • Kontakt:
        • Ledende efterforsker:
          • Bradley R. Corr
      • Greeley, Colorado, Forenede Stater, 80631
        • Rekruttering
        • UCHealth Greeley Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Bradley R. Corr
      • Highlands Ranch, Colorado, Forenede Stater, 80129
        • Rekruttering
        • UCHealth Highlands Ranch Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Ledende efterforsker:
          • Bradley R. Corr
      • Loveland, Colorado, Forenede Stater, 80538
        • Rekruttering
        • Medical Center of the Rockies
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 970-203-7083
        • Ledende efterforsker:
          • Bradley R. Corr
    • Connecticut
      • Hartford, Connecticut, Forenede Stater, 06102
        • Rekruttering
        • Hartford Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 860-545-5363
        • Ledende efterforsker:
          • Amy K. Brown
      • Manchester, Connecticut, Forenede Stater, 06042
        • Rekruttering
        • Hartford HealthCare - Manchester
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 860-972-4700
        • Ledende efterforsker:
          • Amy K. Brown
      • New Britain, Connecticut, Forenede Stater, 06050
        • Rekruttering
        • The Hospital of Central Connecticut
        • Ledende efterforsker:
          • Amy K. Brown
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 860-224-5660
    • Delaware
      • Millville, Delaware, Forenede Stater, 19967
        • Rekruttering
        • Beebe South Coastal Health Campus
        • Kontakt:
        • Ledende efterforsker:
          • Gregory A. Masters
      • Newark, Delaware, Forenede Stater, 19713
        • Rekruttering
        • Helen F Graham Cancer Center
        • Ledende efterforsker:
          • Gregory A. Masters
        • Kontakt:
      • Newark, Delaware, Forenede Stater, 19713
        • Rekruttering
        • Medical Oncology Hematology Consultants PA
        • Ledende efterforsker:
          • Gregory A. Masters
        • Kontakt:
      • Rehoboth Beach, Delaware, Forenede Stater, 19971
        • Rekruttering
        • Beebe Health Campus
        • Kontakt:
        • Ledende efterforsker:
          • Gregory A. Masters
    • District of Columbia
      • Washington D.C., District of Columbia, Forenede Stater, 20010
        • Rekruttering
        • MedStar Washington Hospital Center
        • Ledende efterforsker:
          • Ebony R. Hoskins
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 202-877-8839
    • Florida
      • N. Venice, Florida, Forenede Stater, 34275
        • Rekruttering
        • Sarasota Memorial Hospital-Venice
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 941-261-9000
        • Ledende efterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forenede Stater, 34239
        • Rekruttering
        • Sarasota Memorial Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 941-917-2225
        • Ledende efterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forenede Stater, 34243
        • Rekruttering
        • Sarasota Memorial Health Care Center at University Parkway
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 941-917-6519
        • Ledende efterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forenede Stater, 34239
        • Rekruttering
        • Florida Cancer Specialists - Sarasota Downtown
        • Kontakt:
        • Ledende efterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forenede Stater, 34239
        • Rekruttering
        • FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery
        • Kontakt:
        • Ledende efterforsker:
          • Toni P. Kilts
      • Venice, Florida, Forenede Stater, 34275
        • Rekruttering
        • Florida Cancer Specialists - Venice Pinebrook
        • Kontakt:
        • Ledende efterforsker:
          • Toni P. Kilts
    • Georgia
      • Atlanta, Georgia, Forenede Stater, 30322
        • Rekruttering
        • Emory University Hospital/Winship Cancer Institute
        • Ledende efterforsker:
          • Kristen Starbuck
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 404-778-1868
      • Atlanta, Georgia, Forenede Stater, 30303
        • Rekruttering
        • Grady Health System
        • Ledende efterforsker:
          • Kristen Starbuck
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 404-778-1868
      • Atlanta, Georgia, Forenede Stater, 30308
        • Rekruttering
        • Emory University Hospital Midtown
        • Ledende efterforsker:
          • Kristen Starbuck
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 888-946-7447
      • Augusta, Georgia, Forenede Stater, 30912
        • Rekruttering
        • Augusta University Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Bunja J. Rungruang
      • Decatur, Georgia, Forenede Stater, 30033
    • Hawaii
      • Honolulu, Hawaii, Forenede Stater, 96826
        • Rekruttering
        • Kapiolani Medical Center for Women and Children
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-983-6090
        • Ledende efterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Kontakt:
        • Ledende efterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Queen's Cancer Cenrer - POB I
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-532-0315
        • Ledende efterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forenede Stater, 96813
        • Rekruttering
        • Queen's Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-545-8548
        • Ledende efterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forenede Stater, 96817
        • Rekruttering
        • Queen's Cancer Center - Kuakini
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-531-8521
        • Ledende efterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forenede Stater, 96819
        • Rekruttering
        • Kaiser Permanente Moanalua Medical Center
        • Ledende efterforsker:
          • Juraj Kavecansky
        • Kontakt:
      • ‘Aiea, Hawaii, Forenede Stater, 96701
        • Rekruttering
        • Pali Momi Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-486-6000
        • Ledende efterforsker:
          • Michael E. Carney
      • ‘Aiea, Hawaii, Forenede Stater, 96701
        • Rekruttering
        • Queen's Cancer Center - Pearlridge
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 808-487-7447
        • Ledende efterforsker:
          • Michael E. Carney
      • ‘Ewa Beach, Hawaii, Forenede Stater, 96706
        • Rekruttering
        • The Queen's Medical Center - West Oahu
        • Kontakt:
        • Ledende efterforsker:
          • Michael E. Carney
    • Idaho
      • Coeur d'Alene, Idaho, Forenede Stater, 83814
        • Rekruttering
        • Kootenai Health - Coeur d'Alene
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Post Falls, Idaho, Forenede Stater, 83854
        • Rekruttering
        • Kootenai Clinic Cancer Services - Post Falls
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Sandpoint, Idaho, Forenede Stater, 83864
        • Rekruttering
        • Kootenai Clinic Cancer Services - Sandpoint
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
    • Illinois
      • Chicago, Illinois, Forenede Stater, 60637
        • Rekruttering
        • University of Chicago Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Alyssa Bujnak
      • Chicago, Illinois, Forenede Stater, 60611
        • Rekruttering
        • Northwestern University
        • Kontakt:
        • Ledende efterforsker:
          • Emma Barber
      • Chicago, Illinois, Forenede Stater, 60612
        • Rekruttering
        • Rush MD Anderson Cancer Center
        • Ledende efterforsker:
          • Alexander C. Cohen
        • Kontakt:
      • Danville, Illinois, Forenede Stater, 61832
        • Rekruttering
        • Carle at The Riverfront
        • Ledende efterforsker:
          • Pratima Chalasani
        • Kontakt:
      • DeKalb, Illinois, Forenede Stater, 60115
        • Rekruttering
        • Northwestern Medicine Cancer Center Kishwaukee
        • Kontakt:
        • Ledende efterforsker:
          • Emma Barber
      • Decatur, Illinois, Forenede Stater, 62526
        • Rekruttering
        • Cancer Care Specialists of Illinois - Decatur
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Decatur, Illinois, Forenede Stater, 62526
        • Rekruttering
        • Decatur Memorial Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Effingham, Illinois, Forenede Stater, 62401
        • Rekruttering
        • Carle Physician Group-Effingham
        • Kontakt:
        • Ledende efterforsker:
          • Pratima Chalasani
      • Evanston, Illinois, Forenede Stater, 60201
        • Rekruttering
        • NorthShore University HealthSystem-Evanston Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Geneva, Illinois, Forenede Stater, 60134
        • Rekruttering
        • Northwestern Medicine Cancer Center Delnor
        • Kontakt:
        • Ledende efterforsker:
          • Emma Barber
      • Glenview, Illinois, Forenede Stater, 60026
        • Rekruttering
        • NorthShore University HealthSystem-Glenbrook Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Harvey, Illinois, Forenede Stater, 60426
        • Rekruttering
        • Ingalls Memorial Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Ivy Abraham
      • Highland Park, Illinois, Forenede Stater, 60035
        • Rekruttering
        • NorthShore University HealthSystem-Highland Park Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Ledende efterforsker:
          • Mary T. Jenkins Vogel
      • Mattoon, Illinois, Forenede Stater, 61938
        • Rekruttering
        • Carle Physician Group-Mattoon/Charleston
        • Kontakt:
        • Ledende efterforsker:
          • Pratima Chalasani
      • New Lenox, Illinois, Forenede Stater, 60451
        • Rekruttering
        • UC Comprehensive Cancer Center at Silver Cross
        • Kontakt:
        • Ledende efterforsker:
          • Alyssa Bujnak
      • Normal, Illinois, Forenede Stater, 61761
        • Rekruttering
        • Carle BroMenn Medical Center
        • Ledende efterforsker:
          • Pratima Chalasani
        • Kontakt:
      • Normal, Illinois, Forenede Stater, 61761
        • Rekruttering
        • Carle Cancer Institute Normal
        • Ledende efterforsker:
          • Pratima Chalasani
        • Kontakt:
      • O'Fallon, Illinois, Forenede Stater, 62269
        • Rekruttering
        • Cancer Care Center of O'Fallon
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • O'Fallon, Illinois, Forenede Stater, 62269
        • Rekruttering
        • HSHS Saint Elizabeth's Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Oak Brook, Illinois, Forenede Stater, 60523
      • Oak Park, Illinois, Forenede Stater, 60304
        • Rekruttering
        • Rush MD Anderson Cancer Center at Rush Oak Park
        • Ledende efterforsker:
          • Alexander C. Cohen
        • Kontakt:
      • Orland Park, Illinois, Forenede Stater, 60462
        • Rekruttering
        • University of Chicago Medicine-Orland Park
        • Kontakt:
        • Ledende efterforsker:
          • Alyssa Bujnak
      • Orland Park, Illinois, Forenede Stater, 60462
      • Peoria, Illinois, Forenede Stater, 61637
        • Rekruttering
        • OSF Saint Francis Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Bryan A. Faller
      • Springfield, Illinois, Forenede Stater, 62702
        • Rekruttering
        • Southern Illinois University School of Medicine
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 217-545-7929
      • Springfield, Illinois, Forenede Stater, 62702
        • Rekruttering
        • Springfield Clinic
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-444-7541
      • Springfield, Illinois, Forenede Stater, 62781
        • Rekruttering
        • Springfield Memorial Hospital
        • Ledende efterforsker:
          • Bryan A. Faller
        • Kontakt:
      • Urbana, Illinois, Forenede Stater, 61801
        • Rekruttering
        • Carle Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Pratima Chalasani
      • Warrenville, Illinois, Forenede Stater, 60555
        • Rekruttering
        • Northwestern Medicine Cancer Center Warrenville
        • Kontakt:
        • Ledende efterforsker:
          • Emma Barber
    • Indiana
      • Crown Point, Indiana, Forenede Stater, 46307
        • Rekruttering
        • UChicago Medicine Northwest Indiana
        • Kontakt:
        • Ledende efterforsker:
          • Alyssa Bujnak
      • Goshen, Indiana, Forenede Stater, 46526
        • Rekruttering
        • Goshen Center for Cancer Care
        • Kontakt:
        • Ledende efterforsker:
          • Pamela J. Stone
      • Indianapolis, Indiana, Forenede Stater, 46260
        • Rekruttering
        • Ascension Saint Vincent Indianapolis Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Megan E. Buechel
      • South Bend, Indiana, Forenede Stater, 46601
        • Suspenderet
        • Memorial Hospital of South Bend
    • Iowa
      • Ankeny, Iowa, Forenede Stater, 50023
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Carroll, Iowa, Forenede Stater, 51401
        • Rekruttering
        • Saint Anthony Regional Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Forenede Stater, 52403
        • Rekruttering
        • Mercy Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 319-365-4673
        • Ledende efterforsker:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Forenede Stater, 52403
        • Rekruttering
        • Oncology Associates at Mercy Medical Center
        • Ledende efterforsker:
          • Deborah W. Wilbur
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 319-363-2690
      • Clive, Iowa, Forenede Stater, 50325
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forenede Stater, 50314
        • Rekruttering
        • Broadlawns Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-282-2200
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forenede Stater, 50314
        • Rekruttering
        • Mercy Medical Center - Des Moines
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Richard L. Deming
      • Des Moines, Iowa, Forenede Stater, 50309
        • Rekruttering
        • Iowa Methodist Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-6727
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forenede Stater, 50309
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forenede Stater, 50314
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
      • Fort Dodge, Iowa, Forenede Stater, 50501
        • Rekruttering
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • Ledende efterforsker:
          • Seema Harichand-Herdt
        • Kontakt:
      • Iowa City, Iowa, Forenede Stater, 52242
        • Rekruttering
        • University of Iowa/Holden Comprehensive Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-237-1225
        • Ledende efterforsker:
          • David P. Bender
      • Waukee, Iowa, Forenede Stater, 50263
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Ledende efterforsker:
          • Seema Harichand-Herdt
    • Kentucky
      • Lexington, Kentucky, Forenede Stater, 40536
        • Rekruttering
        • University of Kentucky/Markey Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 859-257-3379
        • Ledende efterforsker:
          • Rachel W. Miller
      • Lexington, Kentucky, Forenede Stater, 40503
        • Rekruttering
        • Baptist Health Lexington
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 859-260-6425
        • Ledende efterforsker:
          • Hope Cottrill
    • Louisiana
      • Marrero, Louisiana, Forenede Stater, 70072
        • Rekruttering
        • West Jefferson Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Tara Castellano
      • Metairie, Louisiana, Forenede Stater, 70006
        • Rekruttering
        • East Jefferson General Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Tara Castellano
      • Metairie, Louisiana, Forenede Stater, 70006
        • Rekruttering
        • LSU Healthcare Network / Metairie Multi-Specialty Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Tara Castellano
      • New Orleans, Louisiana, Forenede Stater, 70112
        • Rekruttering
        • University Medical Center New Orleans
        • Kontakt:
        • Ledende efterforsker:
          • Tara Castellano
    • Maine
      • Brewer, Maine, Forenede Stater, 04412
        • Rekruttering
        • Lafayette Family Cancer Center-EMMC
        • Ledende efterforsker:
          • Sarah J. Sinclair
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-987-3005
      • Scarborough, Maine, Forenede Stater, 04074
        • Rekruttering
        • MaineHealth Maine Medical Center- Scarborough
        • Ledende efterforsker:
          • Leslie S. Bradford
        • Kontakt:
    • Maryland
      • Baltimore, Maryland, Forenede Stater, 21287
        • Rekruttering
        • Johns Hopkins University/Sidney Kimmel Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Amanda N. Fader
      • Baltimore, Maryland, Forenede Stater, 21237
        • Rekruttering
        • MedStar Franklin Square Medical Center/Weinberg Cancer Institute
        • Ledende efterforsker:
          • Ebony R. Hoskins
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 443-777-7364
    • Massachusetts
      • Boston, Massachusetts, Forenede Stater, 02215
        • Rekruttering
        • Dana-Farber Cancer Institute
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 877-442-3324
        • Ledende efterforsker:
          • Susana M. Campos
      • Burlington, Massachusetts, Forenede Stater, 01805
      • Peabody, Massachusetts, Forenede Stater, 01960
    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • Rekruttering
        • University of Michigan Rogel Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Zhen Ni Zhou
      • Battle Creek, Michigan, Forenede Stater, 49017
        • Rekruttering
        • Bronson Battle Creek
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Brighton, Michigan, Forenede Stater, 48114
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Brighton, Michigan, Forenede Stater, 48116
        • Rekruttering
        • University of Michigan - Brighton Center for Specialty Care
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-865-1125
        • Ledende efterforsker:
          • Zhen Ni Zhou
      • Canton, Michigan, Forenede Stater, 48188
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Chelsea, Michigan, Forenede Stater, 48118
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Detroit, Michigan, Forenede Stater, 48201
        • Rekruttering
        • Wayne State University/Karmanos Cancer Institute
        • Ledende efterforsker:
          • Radhika P. Gogoi
        • Kontakt:
      • Escanaba, Michigan, Forenede Stater, 49829
        • Rekruttering
        • OSF Saint Francis Hospital and Medical Group
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Farmington Hills, Michigan, Forenede Stater, 48334
        • Rekruttering
        • Weisberg Cancer Treatment Center
        • Kontakt:
        • Ledende efterforsker:
          • Radhika P. Gogoi
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Genesys Hurley Cancer Institute
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Hurley Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Flint, Michigan, Forenede Stater, 48503
        • Rekruttering
        • Cancer Hematology Centers - Flint
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Grand Rapids, Michigan, Forenede Stater, 49503
        • Rekruttering
        • Trinity Health Grand Rapids Hospital
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Grand Rapids, Michigan, Forenede Stater, 49503
        • Rekruttering
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49007
        • Rekruttering
        • Bronson Methodist Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49007
        • Rekruttering
        • West Michigan Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forenede Stater, 49009
        • Rekruttering
        • Beacon Kalamazoo Cancer Center
        • Ledende efterforsker:
          • Kathleen Y. Butler
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Lansing, Michigan, Forenede Stater, 48912
        • Rekruttering
        • University of Michigan Health - Sparrow Lansing
        • Ledende efterforsker:
          • J. R. Liu
        • Kontakt:
      • Livonia, Michigan, Forenede Stater, 48154
        • Rekruttering
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Manistique, Michigan, Forenede Stater, 49854
        • Rekruttering
        • Schoolcraft Memorial Hospital
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Muskegon, Michigan, Forenede Stater, 49444
        • Rekruttering
        • Trinity Health Muskegon Hospital
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Niles, Michigan, Forenede Stater, 49120
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Niles Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 616-391-1230
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Norton Shores, Michigan, Forenede Stater, 49444
        • Rekruttering
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Pontiac, Michigan, Forenede Stater, 48341
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
      • Reed City, Michigan, Forenede Stater, 49677
        • Rekruttering
        • Corewell Health Reed City Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forenede Stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forenede Stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Traverse City, Michigan, Forenede Stater, 49684
        • Rekruttering
        • Munson Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Wyoming, Michigan, Forenede Stater, 49519
        • Rekruttering
        • University of Michigan Health - West
        • Kontakt:
        • Ledende efterforsker:
          • Kathleen Y. Butler
      • Ypsilanti, Michigan, Forenede Stater, 48197
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Kontakt:
        • Ledende efterforsker:
          • J. R. Liu
    • Minnesota
      • Brainerd, Minnesota, Forenede Stater, 56401
        • Rekruttering
        • Essentia Health Saint Joseph's Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Coon Rapids, Minnesota, Forenede Stater, 55433
        • Rekruttering
        • Mercy Hospital
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Deer River, Minnesota, Forenede Stater, 56636
        • Rekruttering
        • Essentia Health - Deer River Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Duluth, Minnesota, Forenede Stater, 55805
        • Rekruttering
        • Essentia Health Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Edina, Minnesota, Forenede Stater, 55435
        • Rekruttering
        • Fairview Southdale Hospital
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Edina, Minnesota, Forenede Stater, 55435
        • Rekruttering
        • Minnesota Oncology - Edina
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Hibbing, Minnesota, Forenede Stater, 55746
        • Rekruttering
        • Essentia Health Hibbing Clinic
        • Ledende efterforsker:
          • Bret E. Friday
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 218-786-3308
      • Minneapolis, Minnesota, Forenede Stater, 55407
        • Rekruttering
        • Abbott-Northwestern Hospital
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Minneapolis, Minnesota, Forenede Stater, 55455
        • Rekruttering
        • University of Minnesota/Masonic Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 612-624-2620
        • Ledende efterforsker:
          • Alexandra Schefter
      • Saint Louis Park, Minnesota, Forenede Stater, 55416
        • Rekruttering
        • Park Nicollet Clinic - Saint Louis Park
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Saint Paul, Minnesota, Forenede Stater, 55101
        • Rekruttering
        • Regions Hospital
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Saint Paul, Minnesota, Forenede Stater, 55102
        • Rekruttering
        • United Hospital
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
      • Sandstone, Minnesota, Forenede Stater, 55072
        • Rekruttering
        • Essentia Health Sandstone
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Virginia, Minnesota, Forenede Stater, 55792
        • Rekruttering
        • Essentia Health Virginia Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Woodbury, Minnesota, Forenede Stater, 55125
        • Rekruttering
        • Minnesota Oncology Hematology PA-Woodbury
        • Ledende efterforsker:
          • Joleen M. Hubbard
        • Kontakt:
    • Missouri
      • Columbia, Missouri, Forenede Stater, 65212
        • Rekruttering
        • MU Health - University Hospital/Ellis Fischel Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 573-882-7440
        • Ledende efterforsker:
          • Erin R. Tuller
      • Springfield, Missouri, Forenede Stater, 65804
        • Rekruttering
        • Mercy Hospital Springfield
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • Springfield, Missouri, Forenede Stater, 65807
        • Rekruttering
        • CoxHealth South Hospital
        • Ledende efterforsker:
          • Jay W. Carlson
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • St Louis, Missouri, Forenede Stater, 63110
        • Rekruttering
        • Washington University School of Medicine
        • Kontakt:
        • Ledende efterforsker:
          • David G. Mutch
    • Montana
      • Anaconda, Montana, Forenede Stater, 59711
        • Rekruttering
        • Community Hospital of Anaconda
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Billings, Montana, Forenede Stater, 59101
        • Rekruttering
        • Billings Clinic Cancer Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Billings, Montana, Forenede Stater, 59102
        • Rekruttering
        • Saint Vincent Frontier Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-648-6274
        • Ledende efterforsker:
          • Megan Petersen
      • Billings, Montana, Forenede Stater, 59106
        • Rekruttering
        • Intermountain Health West End Clinic
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 406-238-6685
        • Ledende efterforsker:
          • Megan Petersen
      • Bozeman, Montana, Forenede Stater, 59715
        • Rekruttering
        • Bozeman Health Deaconess Hospital
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Great Falls, Montana, Forenede Stater, 59405
        • Rekruttering
        • Benefis Sletten Cancer Institute
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Kalispell, Montana, Forenede Stater, 59901
        • Rekruttering
        • Logan Health Medical Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
      • Missoula, Montana, Forenede Stater, 59804
        • Rekruttering
        • Community Medical Center
        • Ledende efterforsker:
          • John M. Schallenkamp
        • Kontakt:
    • Nebraska
      • Bellevue, Nebraska, Forenede Stater, 68123
        • Rekruttering
        • Nebraska Medicine-Bellevue
        • Kontakt:
        • Ledende efterforsker:
          • Lindsey A. McAlarnen
      • Kearney, Nebraska, Forenede Stater, 68845
        • Rekruttering
        • Fred and Pamela Buffett Cancer Center - Kearney
        • Kontakt:
        • Ledende efterforsker:
          • Lindsey A. McAlarnen
      • Omaha, Nebraska, Forenede Stater, 68198
        • Rekruttering
        • University of Nebraska Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Lindsey A. McAlarnen
      • Omaha, Nebraska, Forenede Stater, 68114
        • Rekruttering
        • Nebraska Methodist Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 402-354-5144
        • Ledende efterforsker:
          • Brent J. Tierney
      • Omaha, Nebraska, Forenede Stater, 68118
        • Rekruttering
        • Nebraska Medicine-Village Pointe
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 402-559-5600
        • Ledende efterforsker:
          • Lindsey A. McAlarnen
    • Nevada
      • Las Vegas, Nevada, Forenede Stater, 89106
        • Rekruttering
        • Women's Cancer Center of Nevada
        • Ledende efterforsker:
          • Nicola M. Spirtos
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 702-851-4672
    • New Jersey
      • Basking Ridge, New Jersey, Forenede Stater, 07920
        • Rekruttering
        • Memorial Sloan Kettering Basking Ridge
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • Camden, New Jersey, Forenede Stater, 08103
        • Rekruttering
        • Cooper Hospital University Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 856-325-6757
        • Ledende efterforsker:
          • Courtney Griffiths
      • Hamilton, New Jersey, Forenede Stater, 08690
        • Rekruttering
        • The Cancer Institute of New Jersey Hamilton
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 609-631-6946
        • Ledende efterforsker:
          • Eugenia Girda
      • Jersey City, New Jersey, Forenede Stater, 07302
        • Rekruttering
        • Jersey City Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Eugenia Girda
      • Livingston, New Jersey, Forenede Stater, 07039
        • Rekruttering
        • Cooperman Barnabas Medical Center
        • Ledende efterforsker:
          • Eugenia Girda
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 973-322-5200
      • Middletown, New Jersey, Forenede Stater, 07748
        • Rekruttering
        • Memorial Sloan Kettering Monmouth
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • Montvale, New Jersey, Forenede Stater, 07645
        • Rekruttering
        • Memorial Sloan Kettering Bergen
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • New Brunswick, New Jersey, Forenede Stater, 08903
        • Rekruttering
        • Rutgers Cancer Institute of New Jersey
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
        • Ledende efterforsker:
          • Eugenia Girda
      • Newark, New Jersey, Forenede Stater, 07101
        • Rekruttering
        • Rutgers New Jersey Medical School
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
        • Ledende efterforsker:
          • Eugenia Girda
      • Paramus, New Jersey, Forenede Stater, 07652
        • Rekruttering
        • The Valley Hospital - Luckow Pavilion
        • Ledende efterforsker:
          • Eleonora Teplinsky
        • Kontakt:
      • Ridgewood, New Jersey, Forenede Stater, 07450
        • Rekruttering
        • Valley Health System Ridgewood Campus
        • Ledende efterforsker:
          • Eleonora Teplinsky
        • Kontakt:
      • Sewell, New Jersey, Forenede Stater, 08080
        • Rekruttering
        • Sidney Kimmel Cancer Center Washington Township
        • Kontakt:
        • Ledende efterforsker:
          • Jessa Suhner
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater, 87106
        • Rekruttering
        • University of New Mexico Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Amaranta D. Craig
    • New York
      • Bay Shore, New York, Forenede Stater, 11706
        • Rekruttering
        • Northwell Health Imbert Cancer Center
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • Commack, New York, Forenede Stater, 11725
        • Rekruttering
        • Memorial Sloan Kettering Commack
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • Flushing, New York, Forenede Stater, 11354
        • Rekruttering
        • Northwell Health Physician Partners at Flushing
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
      • Greenlawn, New York, Forenede Stater, 11740
        • Rekruttering
        • Northwell Health Cancer Institute at Huntington
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • Harrison, New York, Forenede Stater, 10604
        • Rekruttering
        • Memorial Sloan Kettering Westchester
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • Lake Success, New York, Forenede Stater, 11042
        • Rekruttering
        • Northwell Health/Center for Advanced Medicine
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • New York, New York, Forenede Stater, 10065
        • Rekruttering
        • Memorial Sloan Kettering Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • New York, New York, Forenede Stater, 10011
        • Rekruttering
        • Mount Sinai Chelsea
        • Ledende efterforsker:
          • Stephanie V. Blank
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-mail: CCTO@mssm.edu
      • New York, New York, Forenede Stater, 10029
        • Rekruttering
        • Mount Sinai Hospital
        • Ledende efterforsker:
          • Stephanie V. Blank
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-mail: CCTO@mssm.edu
      • New York, New York, Forenede Stater, 10075
        • Rekruttering
        • Lenox Hill Hospital
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • New York, New York, Forenede Stater, 10065
        • Rekruttering
        • Manhattan Eye Ear and Throat Hospital
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-434-4460
      • New York, New York, Forenede Stater, 10019
        • Rekruttering
        • Mount Sinai West
        • Ledende efterforsker:
          • Stephanie V. Blank
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-mail: CCTO@mssm.edu
      • Rego Park, New York, Forenede Stater, 11374
        • Rekruttering
        • Queens Cancer Center
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 718-312-3446
      • Rochester, New York, Forenede Stater, 14642
        • Rekruttering
        • University of Rochester
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 585-275-5830
        • Ledende efterforsker:
          • Rachael Turner
      • Sleepy Hollow, New York, Forenede Stater, 10591
        • Rekruttering
        • Phelps Memorial Hospital Center
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 914-366-1600
      • Staten Island, New York, Forenede Stater, 10305
        • Rekruttering
        • Staten Island University Hospital
        • Ledende efterforsker:
          • Veena S. John
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 718-226-8888
      • Stony Brook, New York, Forenede Stater, 11794
        • Rekruttering
        • Stony Brook University Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-862-2215
        • Ledende efterforsker:
          • Susan M. Lang
      • Syracuse, New York, Forenede Stater, 13210
        • Rekruttering
        • State University of New York Upstate Medical University
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 315-464-5476
        • Ledende efterforsker:
          • Mary J. Cunningham
      • The Bronx, New York, Forenede Stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Einstein Campus
        • Kontakt:
        • Ledende efterforsker:
          • Nicole S. Nevadunsky
      • The Bronx, New York, Forenede Stater, 10467
        • Rekruttering
        • Montefiore Medical Center - Moses Campus
        • Kontakt:
        • Ledende efterforsker:
          • Nicole S. Nevadunsky
      • The Bronx, New York, Forenede Stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Weiler Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Nicole S. Nevadunsky
      • Uniondale, New York, Forenede Stater, 11553
        • Rekruttering
        • Memorial Sloan Kettering Nassau
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Ledende efterforsker:
          • Carol Aghajanian
      • Webster, New York, Forenede Stater, 14580
    • North Carolina
      • Chapel Hill, North Carolina, Forenede Stater, 27599
        • Rekruttering
        • UNC Lineberger Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Olivia D. Lara
      • Clinton, North Carolina, Forenede Stater, 28328
        • Rekruttering
        • Southeastern Medical Oncology Center-Clinton
        • Kontakt:
        • Ledende efterforsker:
          • Samer S. Kasbari
      • Durham, North Carolina, Forenede Stater, 27710
        • Rekruttering
        • Duke University Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 888-275-3853
        • Ledende efterforsker:
          • Jennifer L. McNally
      • Goldsboro, North Carolina, Forenede Stater, 27534
        • Rekruttering
        • Southeastern Medical Oncology Center-Goldsboro
        • Kontakt:
        • Ledende efterforsker:
          • Samer S. Kasbari
      • Jacksonville, North Carolina, Forenede Stater, 28546
        • Rekruttering
        • Southeastern Medical Oncology Center-Jacksonville
        • Ledende efterforsker:
          • Samer S. Kasbari
        • Kontakt:
      • Raleigh, North Carolina, Forenede Stater, 27607
        • Rekruttering
        • Duke Women's Cancer Care Raleigh
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 919-785-4878
        • Ledende efterforsker:
          • Jennifer L. McNally
    • North Dakota
      • Fargo, North Dakota, Forenede Stater, 58103
        • Rekruttering
        • Essentia Health Cancer Center-South University Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
    • Ohio
      • Athens, Ohio, Forenede Stater, 45701
        • Rekruttering
        • OhioHealth O'Bleness Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Beachwood, Ohio, Forenede Stater, 44122
        • Rekruttering
        • UHHS-Chagrin Highlands Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
      • Canton, Ohio, Forenede Stater, 44710
        • Rekruttering
        • Aultman Health Foundation
        • Kontakt:
        • Ledende efterforsker:
          • Sunitha Vemulapalli
      • Chardon, Ohio, Forenede Stater, 44024
        • Rekruttering
        • Geauga Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
      • Cleveland, Ohio, Forenede Stater, 44106
        • Rekruttering
        • Case Western Reserve University
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
      • Columbus, Ohio, Forenede Stater, 43214
        • Rekruttering
        • Columbus Oncology and Hematology Associates Inc
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43214
        • Rekruttering
        • Riverside Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43215
        • Rekruttering
        • Grant Medical Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43228
        • Rekruttering
        • Doctors Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Columbus, Ohio, Forenede Stater, 43210
        • Rekruttering
        • Ohio State University Comprehensive Cancer Center
        • Kontakt:
        • Ledende efterforsker:
          • Floor Backes
      • Delaware, Ohio, Forenede Stater, 43015
        • Rekruttering
        • Delaware Health Center-Grady Cancer Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Delaware, Ohio, Forenede Stater, 43015
        • Rekruttering
        • Grady Memorial Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Dublin, Ohio, Forenede Stater, 43016
        • Rekruttering
        • Columbus Oncology and Hematology Associates
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Dublin, Ohio, Forenede Stater, 43016
        • Rekruttering
        • Dublin Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Mansfield, Ohio, Forenede Stater, 44903
        • Rekruttering
        • OhioHealth Mansfield Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Marion, Ohio, Forenede Stater, 43302
        • Rekruttering
        • OhioHealth Marion General Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Mentor, Ohio, Forenede Stater, 44060
        • Rekruttering
        • UH Seidman Cancer Center at Lake Health Mentor Campus
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
      • Parma, Ohio, Forenede Stater, 44129
        • Rekruttering
        • University Hospitals Parma Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
      • Pickerington, Ohio, Forenede Stater, 43147
        • Rekruttering
        • OhioHealth Pickerington Methodist Hospital
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Sylvania, Ohio, Forenede Stater, 43560
        • Rekruttering
        • ProMedica Flower Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Anjalika Gandhi
      • Westerville, Ohio, Forenede Stater, 43082
        • Rekruttering
        • OhioHealth Westerville Medical Campus/Westerville Cancer Center
        • Ledende efterforsker:
          • Aine E. Clements
        • Kontakt:
      • Westlake, Ohio, Forenede Stater, 44145
        • Rekruttering
        • UH Seidman Cancer Center at Saint John Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Amy Armstrong
    • Oklahoma
      • Oklahoma City, Oklahoma, Forenede Stater, 73104
        • Rekruttering
        • University of Oklahoma Health Sciences Center
        • Kontakt:
        • Ledende efterforsker:
          • Grace Duininck
    • Oregon
      • Portland, Oregon, Forenede Stater, 97213
        • Rekruttering
        • Providence Portland Medical Center
        • Ledende efterforsker:
          • Dan S. Zuckerman
        • Kontakt:
      • Portland, Oregon, Forenede Stater, 97225
        • Rekruttering
        • Providence Saint Vincent Medical Center
        • Ledende efterforsker:
          • Dan S. Zuckerman
        • Kontakt:
      • Portland, Oregon, Forenede Stater, 97210
        • Rekruttering
        • Legacy Good Samaritan Hospital and Medical Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-220-4937
          • E-mail: cancer@lhs.org
        • Ledende efterforsker:
          • Julia Fehniger
      • Tualatin, Oregon, Forenede Stater, 97062
        • Rekruttering
        • Legacy Meridian Park Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 503-413-1742
        • Ledende efterforsker:
          • Julia Fehniger
    • Pennsylvania
      • Erie, Pennsylvania, Forenede Stater, 16505
        • Rekruttering
        • UPMC Hillman Cancer Center Erie
        • Ledende efterforsker:
          • Sarah E. Taylor
        • Kontakt:
      • Greensburg, Pennsylvania, Forenede Stater, 15601
        • Rekruttering
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 724-838-1900
        • Ledende efterforsker:
          • Sarah E. Taylor
      • Hershey, Pennsylvania, Forenede Stater, 17033-0850
        • Rekruttering
        • Penn State Milton S Hershey Medical Center
        • Ledende efterforsker:
          • Mark S. Shahin
        • Kontakt:
      • Mechanicsburg, Pennsylvania, Forenede Stater, 17050
        • Rekruttering
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Kontakt:
        • Ledende efterforsker:
          • Sarah E. Taylor
      • Philadelphia, Pennsylvania, Forenede Stater, 19107
        • Rekruttering
        • Thomas Jefferson University Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Jessa Suhner
      • Philadelphia, Pennsylvania, Forenede Stater, 19114
        • Rekruttering
        • Jefferson Torresdale Hospital
        • Kontakt:
        • Ledende efterforsker:
          • Jessa Suhner
      • Pittsburgh, Pennsylvania, Forenede Stater, 15213
        • Rekruttering
        • UPMC-Magee Womens Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 412-647-2811
        • Ledende efterforsker:
          • Sarah E. Taylor
      • Pittsburgh, Pennsylvania, Forenede Stater, 15237
        • Rekruttering
        • UPMC-Passavant Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 412-367-6454
        • Ledende efterforsker:
          • Sarah E. Taylor
      • Washington, Pennsylvania, Forenede Stater, 15301
        • Rekruttering
        • UPMC Cancer Center-Washington
        • Kontakt:
        • Ledende efterforsker:
          • Sarah E. Taylor
      • Willow Grove, Pennsylvania, Forenede Stater, 19090
        • Rekruttering
        • Asplundh Cancer Pavilion
        • Kontakt:
        • Ledende efterforsker:
          • Jessa Suhner
    • Rhode Island
      • Providence, Rhode Island, Forenede Stater, 02903
        • Rekruttering
        • Rhode Island Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 401-444-1488
        • Ledende efterforsker:
          • Boris Martinez
      • Providence, Rhode Island, Forenede Stater, 02905
        • Rekruttering
        • Women and Infants Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 401-274-1122
        • Ledende efterforsker:
          • Paul A. DiSilvestro
    • Tennessee
      • Franklin, Tennessee, Forenede Stater, 37067
        • Rekruttering
        • Vanderbilt-Ingram Cancer Center Cool Springs
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Ledende efterforsker:
          • Alaina J. Brown
      • Nashville, Tennessee, Forenede Stater, 37232
        • Rekruttering
        • Vanderbilt University/Ingram Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Ledende efterforsker:
          • Alaina J. Brown
      • Nashville, Tennessee, Forenede Stater, 37204
        • Rekruttering
        • Vanderbilt Breast Center at One Hundred Oaks
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Ledende efterforsker:
          • Alaina J. Brown
    • Utah
      • Salt Lake City, Utah, Forenede Stater, 84106
        • Rekruttering
        • University of Utah Sugarhouse Health Center
        • Kontakt:
        • Ledende efterforsker:
          • Talicia Savage
      • Salt Lake City, Utah, Forenede Stater, 84112
        • Rekruttering
        • Huntsman Cancer Institute/University of Utah
        • Kontakt:
        • Ledende efterforsker:
          • Talicia Savage
      • South Jordan, Utah, Forenede Stater, 84009
        • Rekruttering
        • South Jordan Health Center
        • Kontakt:
        • Ledende efterforsker:
          • Talicia Savage
    • Virginia
      • Charlottesville, Virginia, Forenede Stater, 22908
      • Richmond, Virginia, Forenede Stater, 23298
        • Rekruttering
        • VCU Massey Comprehensive Cancer Center
        • Ledende efterforsker:
          • Jaclyn Wall
        • Kontakt:
    • Washington
      • Edmonds, Washington, Forenede Stater, 98026
        • Rekruttering
        • Swedish Cancer Institute-Edmonds
        • Ledende efterforsker:
          • Dan S. Zuckerman
        • Kontakt:
      • Issaquah, Washington, Forenede Stater, 98029
        • Rekruttering
        • Swedish Cancer Institute-Issaquah
        • Ledende efterforsker:
          • Dan S. Zuckerman
        • Kontakt:
      • Seattle, Washington, Forenede Stater, 98122
        • Rekruttering
        • Swedish Medical Center-First Hill
        • Ledende efterforsker:
          • Dan S. Zuckerman
        • Kontakt:
      • Seattle, Washington, Forenede Stater, 98195
        • Rekruttering
        • University of Washington Medical Center - Montlake
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-804-8824
        • Ledende efterforsker:
          • Heidi J. Gray
      • Seattle, Washington, Forenede Stater, 98109
        • Rekruttering
        • Fred Hutchinson Cancer Center
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 800-804-8824
        • Ledende efterforsker:
          • Heidi J. Gray
      • Vancouver, Washington, Forenede Stater, 98686
        • Rekruttering
        • Legacy Salmon Creek Hospital
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 503-413-2150
        • Ledende efterforsker:
          • Julia Fehniger
    • West Virginia
      • Bridgeport, West Virginia, Forenede Stater, 26330
        • Rekruttering
        • United Hospital Center
        • Kontakt:
        • Ledende efterforsker:
          • Krista S. Pfaendler
      • Charleston, West Virginia, Forenede Stater, 25304
        • Rekruttering
        • Vandalia Health/CAMC Institute for Academic Medicine
        • Ledende efterforsker:
          • Stephen H. Bush
        • Kontakt:
      • Martinsburg, West Virginia, Forenede Stater, 25401
        • Rekruttering
        • WVUH-Berkely Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Krista S. Pfaendler
      • Morgantown, West Virginia, Forenede Stater, 26506
        • Rekruttering
        • West Virginia University Healthcare
        • Kontakt:
        • Ledende efterforsker:
          • Krista S. Pfaendler
      • Parkersburg, West Virginia, Forenede Stater, 26101
        • Rekruttering
        • Camden Clark Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Krista S. Pfaendler
    • Wisconsin
      • Ashland, Wisconsin, Forenede Stater, 54806
        • Rekruttering
        • Duluth Clinic Ashland
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Green Bay, Wisconsin, Forenede Stater, 54301
        • Rekruttering
        • Saint Vincent Hospital Cancer Center Green Bay
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Green Bay, Wisconsin, Forenede Stater, 54303
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • La Crosse, Wisconsin, Forenede Stater, 54601
        • Rekruttering
        • Gundersen Lutheran Medical Center
        • Kontakt:
        • Ledende efterforsker:
          • Gil Harmon
      • Milwaukee, Wisconsin, Forenede Stater, 53226
        • Rekruttering
        • Medical College of Wisconsin
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 414-805-3666
        • Ledende efterforsker:
          • William H. Bradley
      • Oconto Falls, Wisconsin, Forenede Stater, 54154
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Sheboygan, Wisconsin, Forenede Stater, 53081
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Sheboygan, Wisconsin, Forenede Stater, 53081
        • Rekruttering
        • Sheboygan Physicians Group
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Spooner, Wisconsin, Forenede Stater, 54801
        • Rekruttering
        • Essentia Health-Spooner Clinic
        • Kontakt:
        • Ledende efterforsker:
          • Bret E. Friday
      • Sturgeon Bay, Wisconsin, Forenede Stater, 54235-1495
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Ledende efterforsker:
          • Matthew L. Ryan
        • Kontakt:
      • Superior, Wisconsin, Forenede Stater, 54880
        • Rekruttering
        • Essentia Health Saint Mary's Hospital - Superior
        • Ledende efterforsker:
          • Bret E. Friday
        • Kontakt:
          • Site Public Contact
          • Telefonnummer: 701-364-6272

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • Documentation of disease:

    • Stage III and stage IVA endometrial cancers (with measurable disease),
    • Stage IVB endometrial cancer (with or without measurable disease), or
    • Recurrent endometrial cancer (with or without measurable disease)
  • In patients with measurable disease, lesions will be defined and monitored by RECIST 1.1. Measurable disease (RECIST 1.1) is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be ≥ 10 mm when measured by CT or MRI. Lymph nodes must be ≥ 15 mm in short axis when measured by CT or MRI

  • Histologic confirmation of the original primary tumor is required (submission of pathology report[s] is required). Patients with the following histologic types are eligible: endometrioid, serous, dedifferentiated/undifferentiated, clear cell, mixed epithelial, carcinosarcoma, adenocarcinoma not otherwise specified (N.O.S.)

  • Patients must have:

    • Tumoral mismatch repair proficient (pMMR) disease as assessed by immunohistochemistry (IHC) AND
    • P53 IHC with aberrant staining pattern (aberrant p53 expression is consistent with mutant TP53). TP53 mutation by next-generation sequencing will also be accepted
  • A pathology report demonstrating results of institutional MMR IHC and p53 IHC and/or TP53 by next-generation sequencing

  • Patients may have received:

    • NO prior chemotherapy for treatment of endometrial cancer OR
    • Prior adjuvant chemotherapy (e.g., paclitaxel/carboplatin alone or as a component of concurrent chemotherapy and radiation therapy [with or without cisplatin]) provided adjuvant chemotherapy was completed ≥ 12 months prior to registration
  • Patients may have received prior radiation therapy for treatment of endometrial cancer. Prior radiation therapy may have included pelvic radiation therapy, extended field pelvic/para-aortic radiation therapy, intravaginal brachytherapy, and/or palliative radiation therapy. All radiation therapy must be completed at least 4 weeks prior to registration. For patients with recent radiation, they must have RECIST-evaluable disease outside of the radiation field and have recovered their marrow function

  • Patients may have received prior hormonal (endocrine) therapy. All hormonal (endocrine) therapy must have been completed at least 1 week prior to registration

  • NO prior pembrolizumab (or other anti-PD1, anti-PDL1 or anti-CTLA4 therapy) or bevacizumab (or other antiangiogenic therapy)

  • Interval or cytoreductive surgery, after start of treatment on this trial, and prior to documentation of disease progression, is NOT permitted

  • Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of disease progression. Patients with brain metastases must have follow up imaging demonstrating no evidence of disease progression and that the disease is stable off of steroids

  • Age ≥ 18

  • Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2

  • Not pregnant and not nursing

  • Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3

  • Platelets ≥ 100,000 cells/mm^3

  • Hemoglobin ≥ 8 g/dl

  • Creatinine clearance (CrCl) of ≥ 30 mL/min by the Cockcroft-Gault formula

  • Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x institutional ULN may be enrolled)

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x institutional ULN

  • Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class II or better

  • No active infection requiring parenteral antibiotics

  • No current evidence of intra-abdominal abscess, abdominal/pelvic fistula (not diverted), gastrointestinal perforation, gastrointestinal (GI) obstruction, and/or need for drainage nasogastric or gastrostomy tube

  • No clinically significant bleeding within 28 days prior to registration

  • No uncontrolled hypertension, defined as systolic ≥ 160 mm Hg or diastolic ≥ 100 mm Hg

  • No major surgery within 28 days of initiation of bevacizumab

  • No active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease

    • Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible
    • Topical or inhaled steroids are allowed
    • Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), and anti-thyroid antibodies should be evaluated with the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible
  • No history of (non-infectious) pneumonitis that required steroids, or current pneumonitis

  • No history of stem cell or solid organ transplant

  • No history of allergic reaction to the study agent(s) or compounds of similar chemical or biologic composition to the study agent(s) (or any of its excipients)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Arm 1 (paclitaxel, carboplatin, pembrolizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional 14 cycles. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navne:
  • Blastocarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Carboplatin
  • Carbosin
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatin
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navne:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Given IV

Andre navne:
  • Keytruda
  • MK-3475
  • Lambrolizumab
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumab Biosimilar BCD-201
  • Pembrolizumab Biosimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumab Biosimilar GME751
  • MK 3475
  • SCH900475
  • Pembrolizumab Biosimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab Biosimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo urine and blood sample collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: Arm 2 (paclitaxel, carboplatin, bevacizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navne:
  • Blastocarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Carboplatin
  • Carbosin
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatin
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navne:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Given IV

Andre navne:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humaniseret monoklonalt antistof
  • Anti-VEGF monoklonalt antistof SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Immunoglobulin G1 (human-mus monoklonal rhuMab-VEGF gammakæde anti-human vaskulær endotelvækstfaktor), disulfid med human-mus monoklonal rhuMab-VEGF let kæde, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinant humaniseret anti-VEGF monoklonalt antistof
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-equi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • CT P16
  • CTP16
  • Ensartet
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Undergo urine and blood sample collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion
Eksperimentel: Arm 3 (paclitaxel, carboplatin, pembrolizumab, bevacizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navne:
  • Blastocarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Carboplatin
  • Carbosin
  • Carbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatin
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navne:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Given IV

Andre navne:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humaniseret monoklonalt antistof
  • Anti-VEGF monoklonalt antistof SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Immunoglobulin G1 (human-mus monoklonal rhuMab-VEGF gammakæde anti-human vaskulær endotelvækstfaktor), disulfid med human-mus monoklonal rhuMab-VEGF let kæde, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinant humaniseret anti-VEGF monoklonalt antistof
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-equi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • CT P16
  • CTP16
  • Ensartet
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Undergo CT

Andre navne:
  • CT
  • KAT
  • CAT-scanning
  • Beregnet aksial tomografi
  • Computerstyret aksial tomografi
  • Computerstyret tomografi
  • CT-scanning
  • tomografi
  • Computerstyret aksial tomografi (procedure)
  • Computerstyret tomografi (CT) scanning
  • Diagnostisk CAT -scanning
  • Diagnostic CAT Scan Service Type

Undergo MRI

Andre navne:
  • MR
  • Magnetisk resonans
  • Magnetisk resonansbilledscanning
  • Medicinsk billeddannelse, magnetisk resonans / kernemagnetisk resonans
  • HR
  • MR billeddannelse
  • MR-scanning
  • NMR billeddannelse
  • NMRI
  • Kernemagnetisk resonansbilleddannelse
  • Magnetisk resonansbilleddannelse (MRI)
  • sMRI
  • Magnetisk resonansbilleddannelse (procedure)
  • MRI'er
  • Strukturel MR

Given IV

Andre navne:
  • Keytruda
  • MK-3475
  • Lambrolizumab
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumab Biosimilar BCD-201
  • Pembrolizumab Biosimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumab Biosimilar GME751
  • MK 3475
  • SCH900475
  • Pembrolizumab Biosimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab Biosimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo urine and blood sample collection

Andre navne:
  • Biologisk prøvesamling
  • Bioprøve indsamlet
  • Prøvesamling
  • Prøvekollektion

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Progression-free survival (PFS)
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will be defined using Response Evaluation Criteria in Solid Tumors version (v) 1.1. Will be tested using one-sided log-rank tests with α-levels stratified by factors used in the randomization. Patients will be grouped by their randomized treatment assignment for intention-to-treat (ITT) analyses, supported by patients in ITT population. Treatment hazard ratios and their 95% confidence intervals will be estimated using a Cox proportional hazards models specified with a main effect for the randomized treatment assignment and stratified using the stratification factors applied at randomization.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Overall survival (OS)
Tidsramme: From study entry to time of death from any cause, assessed up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for treatment (with Arm 1 as the reference arm).

From study entry to time of death from any cause, assessed up to 5 years
Prognostic and predictive associations of type of TP53 mutation status with PFS
Tidsramme: Up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups.

Up to 5 years
Prognostic and predictive associations of type of TP53 mutation status with OS
Tidsramme: Up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups.

Up to 5 years
Incidence of adverse events (AEs) in treatment with bevacizumab when combined with carboplatin, paclitaxel, and pembrolizumab
Tidsramme: Up to 90 days after last dose of study treatment

The nature, frequency, and degree of toxicity will be tabulated at the system organ class and AE-specific term levels using Common Terminology Criteria for Adverse Events v 5.0. Each patient will be represented according to maximum grade observed for each term. Tabulations will show the number and percentage of patients by maximum grade, within the treatment group received, regardless of the randomized treatment assignment. No specific hypothesis test is pre-specified.

Up to 90 days after last dose of study treatment
Objective response rate
Tidsramme: Within 12 months of initiating therapy

Will be defined as the binomial proportion of evaluable patients with a best overall response of complete response or partial response. Will be supported by their 2-sided, 95% Wilson-Score confidence intervals. The relative odds of response in each experimental group (vs the reference group) will be estimated using a multivariable logistic regression model specified with main effects for the treatment groups and stratified by the stratification factors reported at baseline.

Within 12 months of initiating therapy

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by sex.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by race.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by ethnicity.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Efterforskere

  • Ledende efterforsker: Amanda N Fader, NRG Oncology

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

27. januar 2026

Primær færdiggørelse (Anslået)

1. juli 2028

Studieafslutning (Anslået)

1. juli 2028

Datoer for studieregistrering

Først indsendt

27. september 2025

Først indsendt, der opfyldte QC-kriterier

27. september 2025

Først opslået (Faktiske)

30. september 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

20. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

18. november 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • NCI-2025-06974
  • U10CA180868 (U.S. NIH-bevilling/kontrakt)
  • NCI-2025-06974 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
  • NRG-GY035 (Anden identifikator: CTEP)
  • NRG-GY035 (Anden identifikator: NRG Oncology)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .